165 related articles for article (PubMed ID: 26329581)
1. The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth.
Cao J; Dai X; Wan L; Wang H; Zhang J; Goff PS; Sviderskaya EV; Xuan Z; Xu Z; Xu X; Hinds P; Flaherty KT; Faller DV; Goding CR; Wang Y; Wei W; Cui R
Sci Signal; 2015 Sep; 8(392):ra87. PubMed ID: 26329581
[TBL] [Abstract][Full Text] [Related]
2. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.
Bartlett D; Boyle GM; Ziman M; Medic S
PLoS One; 2015; 10(4):e0124154. PubMed ID: 25880082
[TBL] [Abstract][Full Text] [Related]
4. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
[TBL] [Abstract][Full Text] [Related]
5. Studies on the Contribution of Human Cytomegalovirus UL21a and UL97 to Viral Growth and Inactivation of the Anaphase-Promoting Complex/Cyclosome (APC/C) E3 Ubiquitin Ligase Reveal a Unique Cellular Mechanism for Downmodulation of the APC/C Subunits APC1, APC4, and APC5.
Clark AE; Spector DH
J Virol; 2015 Jul; 89(13):6928-39. PubMed ID: 25903336
[TBL] [Abstract][Full Text] [Related]
6. PAX3 across the spectrum: from melanoblast to melanoma.
Medic S; Ziman M
Crit Rev Biochem Mol Biol; 2009 Jun; 44(2-3):85-97. PubMed ID: 19401874
[TBL] [Abstract][Full Text] [Related]
7. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
8. TBX2 expression is regulated by PAX3 in the melanocyte lineage.
Liu F; Cao J; Lv J; Dong L; Pier E; Xu GX; Wang RA; Xu Z; Goding C; Cui R
Pigment Cell Melanoma Res; 2013 Jan; 26(1):67-77. PubMed ID: 23020925
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta targets PAX3 to control melanocyte differentiation.
Moustakas A
Dev Cell; 2008 Dec; 15(6):797-9. PubMed ID: 19081068
[TBL] [Abstract][Full Text] [Related]
10. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
Wan L; Chen M; Cao J; Dai X; Yin Q; Zhang J; Song SJ; Lu Y; Liu J; Inuzuka H; Katon JM; Berry K; Fung J; Ng C; Liu P; Song MS; Xue L; Bronson RT; Kirschner MW; Cui R; Pandolfi PP; Wei W
Cancer Discov; 2017 Apr; 7(4):424-441. PubMed ID: 28174173
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase 1-dependent activation of APC/C ubiquitin ligase.
Fujimitsu K; Grimaldi M; Yamano H
Science; 2016 May; 352(6289):1121-4. PubMed ID: 27103671
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
[TBL] [Abstract][Full Text] [Related]
13. RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex.
Brown NG; VanderLinden R; Watson ER; Qiao R; Grace CR; Yamaguchi M; Weissmann F; Frye JJ; Dube P; Ei Cho S; Actis ML; Rodrigues P; Fujii N; Peters JM; Stark H; Schulman BA
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5272-9. PubMed ID: 25825779
[TBL] [Abstract][Full Text] [Related]
14. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth.
Lasorella A; Stegmüller J; Guardavaccaro D; Liu G; Carro MS; Rothschild G; de la Torre-Ubieta L; Pagano M; Bonni A; Iavarone A
Nature; 2006 Jul; 442(7101):471-4. PubMed ID: 16810178
[TBL] [Abstract][Full Text] [Related]
15. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
16. Insights into the cellular mechanism of the yeast ubiquitin ligase APC/C-Cdh1 from the analysis of in vivo degrons.
Arnold L; Höckner S; Seufert W
Mol Biol Cell; 2015 Mar; 26(5):843-58. PubMed ID: 25540434
[TBL] [Abstract][Full Text] [Related]
17. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.
Pfleger CM; Kirschner MW
Genes Dev; 2000 Mar; 14(6):655-65. PubMed ID: 10733526
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro.
Wang Q; Kumar S; Slevin M; Kumar P
Cancer Res; 2006 Sep; 66(17):8574-80. PubMed ID: 16951170
[TBL] [Abstract][Full Text] [Related]
19. Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity.
He SJ; Stevens G; Braithwaite AW; Eccles MR
Mol Cancer Ther; 2005 Jun; 4(6):996-1003. PubMed ID: 15956257
[TBL] [Abstract][Full Text] [Related]
20. Cdh1 inhibits WWP2-mediated ubiquitination of PTEN to suppress tumorigenesis in an APC-independent manner.
Liu J; Wan L; Liu J; Yuan Z; Zhang J; Guo J; Malumbres M; Liu J; Zou W; Wei W
Cell Discov; 2016; 2():15044. PubMed ID: 27462441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
